Mallinckrodt Breached Pain Med Licensing Deal, Nuvo Says
Drug giant Mallinckrodt Inc. was sued on Tuesday by pain medication firm Nuvo Research Inc., which accuses it of jeopardizing the approval prospects of Nuvo drug Pennsaid Plus and breaching a...To view the full article, register now.
Already a subscriber? Click here to view full article